Click here to subscribe to our newsletter
|
| |
 |
Industry Insights |
|
| |
Medical Device Firms To Be On Toes For Premarket Submissions
There is a surge in fraudulent, unreliable lab testing concerning premarket submission and the FDA has asked to carefully evaluate the third parties involved.
|
|
|
|
| |
|
|
| |
|
|
FHIR-Based Oncology Standards Adopted By EHR Developers
Leading EHR providers have voluntarily pledged to continue adopting USCDI+ Cancer, which is a minimal set of key cancer-related data features that is advised.
|
|
| |
|
|
| |
Price Transparency Compliance From US Hospitals Diminishes
Federal price transparency laws look non-compliant as data pertaining to the same from US Hospitals shows a dip compared to 2023, says Patient Rights Advocate.
|
|
|
|
| |
|
|
| |
|
|
Post Change Cyberattack, CMS Offers Provider Flexibilities
Due to the outage at Change and the subsequent piling up of financial challenges, the CMS in the US has gone on to offer providers numerous flexibilities.
|
|
| |
|
|
| |
Making Medicare Drug Pricing Power Robust Proposed By Biden
The White House is looking to grant Medicare the authority to negotiate the prices of 50 drugs every year, a significant jump from the present 20 within IRA.
|
|
|
|
| |
|
|
| |
|
|
Congress, HHS Urged To Lessen The Effect of The Change Hack
Provider groups like American Hospital Association & American Medical Association have pushed the federal government to go ahead and offer more financial aid.
|
|
| |
|
|
|
